3SBio Inc. (HKG:1530)
30.90
-1.40 (-4.33%)
Aug 6, 2025, 11:59 AM HKT
3SBio Employees
3SBio had 5,577 employees as of December 31, 2024. The number of employees increased by 166 or 3.07% compared to the previous year.
Employees
5,577
Change (1Y)
166
Growth (1Y)
3.07%
Revenue / Employee
$1,737,934
Profits / Employee
$398,863
Market Cap
77.26B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5,577 | 166 | 3.07% |
Dec 31, 2023 | 5,411 | 198 | 3.80% |
Dec 31, 2022 | 5,213 | -79 | -1.49% |
Dec 31, 2021 | 5,292 | -236 | -4.27% |
Dec 31, 2020 | 5,528 | 124 | 2.29% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
BeOne Medicines | 11,000 |
Hansoh Pharmaceutical Group Company | 8,989 |
Innovent Biologics | 5,659 |
JD Health International | 3,564 |
Akeso | 3,035 |
Sino Biopharmaceutical | 24,379 |
WuXi Biologics | 12,575 |
CSPC Pharmaceutical Group | 21,400 |
3SBio News
- 11 days ago - Pfizer, Chinese biotech firm 3SBio complete licensing deal for cancer drug - South China Morning Post
- 2 months ago - Pfizer's Mega Deal Highlights China's Rising Role In Global Pharma - Benzinga
- 2 months ago - Pfizer Thinks Bigger With 3SBio Deal - Seeking Alpha
- 2 months ago - Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China - Investopedia
- 2 months ago - Pfizer strikes deal with China's 3SBio to license cancer drug - CNBC
- 2 months ago - Pfizer Secures Global Rights To China's 3SBio's Cancer Drug In $6 Billion Deal - Benzinga